Reducing the risk of HIV infection associated with illicit drug use

Mark W. Kline, Robert J. Boyle, Donna C. Futterman, Peter L. Havens, Lisa M. Henry-Reid, Susan King, Lorry Rubin, Jeanne Christensen Lindros

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Substance abuse, specifically the use of illicit drugs that are administered intravenously, continues to play a role in the transmission of human immunodeficiency virus type 1 (HIV-1) among adolescents and young adults (youth). Risks of HIV-1 infection may result from direct exposure to contaminated blood through sharing of injection drug equipment and from unsafe sexual practices (while under the influence of drugs and/or in exchange for drugs). Reducing the risk of HIV-1 infection that is associated with illicit drug use requires prevention education and prompt engagement in treatment. Providing patients with education, instruction on decontamination of used injection drug equipment, improved access to sterile syringes and needles, and postexposure prophylaxis may decrease their risk of acquiring HIV-1 infection. Pediatricians should assess risk behaviors as part of every health care encounter, including queries about tobacco, alcohol, and marijuana use. The risks and benefits of postexposure prophylaxis with antiretroviral drugs should be considered for youth with a single recent (within 72 hours) high-risk exposure to HIV-1 through sharing needles/syringes with an HIV-1-infected individual or having unprotected intercourse with an individual who engages in injection drug use. Such prophylaxis must be accompanied by risk-reduction counseling, appropriate referrals for treatment, and evaluation for pregnancy and associated sexually transmitted infections. There is an urgent need for more substance-abuse prevention and treatment programs, legislation that facilitates unencumbered access to sterile syringes, and expedient availability of reproductive health care services for sexually active youth, including voluntary HIV-1 counseling and testing.

Original languageEnglish (US)
Pages (from-to)566-571
Number of pages6
JournalPediatrics
Volume117
Issue number2
DOIs
StatePublished - Feb 2006
Externally publishedYes

Fingerprint

Street Drugs
HIV Infections
HIV-1
Virus Diseases
Needle Sharing
Pharmaceutical Preparations
Syringes
Injections
Substance-Related Disorders
Counseling
Reproductive Health Services
Delivery of Health Care
Equipment and Supplies
Decontamination
Patient Education
Risk Reduction Behavior
Cannabis
Sexually Transmitted Diseases
Risk-Taking
Legislation

Keywords

  • Adolescents
  • HIV-1
  • Human immunodeficiency virus
  • Injection drug use
  • Needle exchange
  • Postexposure prophylaxis
  • Substance abuse
  • Youth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Kline, M. W., Boyle, R. J., Futterman, D. C., Havens, P. L., Henry-Reid, L. M., King, S., ... Lindros, J. C. (2006). Reducing the risk of HIV infection associated with illicit drug use. Pediatrics, 117(2), 566-571. https://doi.org/10.1542/peds.2005-2750

Reducing the risk of HIV infection associated with illicit drug use. / Kline, Mark W.; Boyle, Robert J.; Futterman, Donna C.; Havens, Peter L.; Henry-Reid, Lisa M.; King, Susan; Rubin, Lorry; Lindros, Jeanne Christensen.

In: Pediatrics, Vol. 117, No. 2, 02.2006, p. 566-571.

Research output: Contribution to journalArticle

Kline, MW, Boyle, RJ, Futterman, DC, Havens, PL, Henry-Reid, LM, King, S, Rubin, L & Lindros, JC 2006, 'Reducing the risk of HIV infection associated with illicit drug use', Pediatrics, vol. 117, no. 2, pp. 566-571. https://doi.org/10.1542/peds.2005-2750
Kline MW, Boyle RJ, Futterman DC, Havens PL, Henry-Reid LM, King S et al. Reducing the risk of HIV infection associated with illicit drug use. Pediatrics. 2006 Feb;117(2):566-571. https://doi.org/10.1542/peds.2005-2750
Kline, Mark W. ; Boyle, Robert J. ; Futterman, Donna C. ; Havens, Peter L. ; Henry-Reid, Lisa M. ; King, Susan ; Rubin, Lorry ; Lindros, Jeanne Christensen. / Reducing the risk of HIV infection associated with illicit drug use. In: Pediatrics. 2006 ; Vol. 117, No. 2. pp. 566-571.
@article{5c766a563c5e45518dc2e4d65ba46321,
title = "Reducing the risk of HIV infection associated with illicit drug use",
abstract = "Substance abuse, specifically the use of illicit drugs that are administered intravenously, continues to play a role in the transmission of human immunodeficiency virus type 1 (HIV-1) among adolescents and young adults (youth). Risks of HIV-1 infection may result from direct exposure to contaminated blood through sharing of injection drug equipment and from unsafe sexual practices (while under the influence of drugs and/or in exchange for drugs). Reducing the risk of HIV-1 infection that is associated with illicit drug use requires prevention education and prompt engagement in treatment. Providing patients with education, instruction on decontamination of used injection drug equipment, improved access to sterile syringes and needles, and postexposure prophylaxis may decrease their risk of acquiring HIV-1 infection. Pediatricians should assess risk behaviors as part of every health care encounter, including queries about tobacco, alcohol, and marijuana use. The risks and benefits of postexposure prophylaxis with antiretroviral drugs should be considered for youth with a single recent (within 72 hours) high-risk exposure to HIV-1 through sharing needles/syringes with an HIV-1-infected individual or having unprotected intercourse with an individual who engages in injection drug use. Such prophylaxis must be accompanied by risk-reduction counseling, appropriate referrals for treatment, and evaluation for pregnancy and associated sexually transmitted infections. There is an urgent need for more substance-abuse prevention and treatment programs, legislation that facilitates unencumbered access to sterile syringes, and expedient availability of reproductive health care services for sexually active youth, including voluntary HIV-1 counseling and testing.",
keywords = "Adolescents, HIV-1, Human immunodeficiency virus, Injection drug use, Needle exchange, Postexposure prophylaxis, Substance abuse, Youth",
author = "Kline, {Mark W.} and Boyle, {Robert J.} and Futterman, {Donna C.} and Havens, {Peter L.} and Henry-Reid, {Lisa M.} and Susan King and Lorry Rubin and Lindros, {Jeanne Christensen}",
year = "2006",
month = "2",
doi = "10.1542/peds.2005-2750",
language = "English (US)",
volume = "117",
pages = "566--571",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Reducing the risk of HIV infection associated with illicit drug use

AU - Kline, Mark W.

AU - Boyle, Robert J.

AU - Futterman, Donna C.

AU - Havens, Peter L.

AU - Henry-Reid, Lisa M.

AU - King, Susan

AU - Rubin, Lorry

AU - Lindros, Jeanne Christensen

PY - 2006/2

Y1 - 2006/2

N2 - Substance abuse, specifically the use of illicit drugs that are administered intravenously, continues to play a role in the transmission of human immunodeficiency virus type 1 (HIV-1) among adolescents and young adults (youth). Risks of HIV-1 infection may result from direct exposure to contaminated blood through sharing of injection drug equipment and from unsafe sexual practices (while under the influence of drugs and/or in exchange for drugs). Reducing the risk of HIV-1 infection that is associated with illicit drug use requires prevention education and prompt engagement in treatment. Providing patients with education, instruction on decontamination of used injection drug equipment, improved access to sterile syringes and needles, and postexposure prophylaxis may decrease their risk of acquiring HIV-1 infection. Pediatricians should assess risk behaviors as part of every health care encounter, including queries about tobacco, alcohol, and marijuana use. The risks and benefits of postexposure prophylaxis with antiretroviral drugs should be considered for youth with a single recent (within 72 hours) high-risk exposure to HIV-1 through sharing needles/syringes with an HIV-1-infected individual or having unprotected intercourse with an individual who engages in injection drug use. Such prophylaxis must be accompanied by risk-reduction counseling, appropriate referrals for treatment, and evaluation for pregnancy and associated sexually transmitted infections. There is an urgent need for more substance-abuse prevention and treatment programs, legislation that facilitates unencumbered access to sterile syringes, and expedient availability of reproductive health care services for sexually active youth, including voluntary HIV-1 counseling and testing.

AB - Substance abuse, specifically the use of illicit drugs that are administered intravenously, continues to play a role in the transmission of human immunodeficiency virus type 1 (HIV-1) among adolescents and young adults (youth). Risks of HIV-1 infection may result from direct exposure to contaminated blood through sharing of injection drug equipment and from unsafe sexual practices (while under the influence of drugs and/or in exchange for drugs). Reducing the risk of HIV-1 infection that is associated with illicit drug use requires prevention education and prompt engagement in treatment. Providing patients with education, instruction on decontamination of used injection drug equipment, improved access to sterile syringes and needles, and postexposure prophylaxis may decrease their risk of acquiring HIV-1 infection. Pediatricians should assess risk behaviors as part of every health care encounter, including queries about tobacco, alcohol, and marijuana use. The risks and benefits of postexposure prophylaxis with antiretroviral drugs should be considered for youth with a single recent (within 72 hours) high-risk exposure to HIV-1 through sharing needles/syringes with an HIV-1-infected individual or having unprotected intercourse with an individual who engages in injection drug use. Such prophylaxis must be accompanied by risk-reduction counseling, appropriate referrals for treatment, and evaluation for pregnancy and associated sexually transmitted infections. There is an urgent need for more substance-abuse prevention and treatment programs, legislation that facilitates unencumbered access to sterile syringes, and expedient availability of reproductive health care services for sexually active youth, including voluntary HIV-1 counseling and testing.

KW - Adolescents

KW - HIV-1

KW - Human immunodeficiency virus

KW - Injection drug use

KW - Needle exchange

KW - Postexposure prophylaxis

KW - Substance abuse

KW - Youth

UR - http://www.scopus.com/inward/record.url?scp=33644860994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644860994&partnerID=8YFLogxK

U2 - 10.1542/peds.2005-2750

DO - 10.1542/peds.2005-2750

M3 - Article

C2 - 16452382

AN - SCOPUS:33644860994

VL - 117

SP - 566

EP - 571

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -